TY - JOUR
T1 - Global approaches to cardiogenetic evaluation after sudden cardiac death in the young
T2 - A survey among health care professionals
AU - van den Heuvel, Lieke M.
AU - Do, Judy
AU - Yeates, Laura
AU - MacLeod, Heather
AU - James, Cynthia A.
AU - Duflou, Johan
AU - Skinner, Jonathan R.
AU - Semsarian, Christopher
AU - van Tintelen, J. Peter
AU - Ingles, Jodie
N1 - Funding Information:
Funding sources: This work was supported by the Netherlands Cardiovascular Research Initiative, an initiative with support of the Dutch Heart Foundation (2015-12 eDETECT), and the eDETECT Young Talent Fund to Lieke M. van den Heuvel. Laura Yeates is a recipient of a co-funded National Heart Foundation of Australia / National Health and Medical Research Council (NHMRC) PhD Scholarship (#102568/#191351). Dr Semsarian is the recipient of a National Health and Medical Research Council (NHMRC) Practitioner Fellowship (#1154992). Dr Ingles is the recipient of an NHMRC Career Development Fellowship (#1162929).
Funding Information:
Funding sources: This work was supported by the Netherlands Cardiovascular Research Initiative, an initiative with support of the Dutch Heart Foundation (2015-12 eDETECT), and the eDETECT Young Talent Fund to Lieke M. van den Heuvel. Laura Yeates is a recipient of a co-funded National Heart Foundation of Australia/National Health and Medical Research Council (NHMRC) PhD Scholarship (#102568/#191351). Dr Semsarian is the recipient of a National Health and Medical Research Council (NHMRC) Practitioner Fellowship (#1154992). Dr Ingles is the recipient of an NHMRC Career Development Fellowship (#1162929).
Funding Information:
Disclosures: Dr James receives research grant support from Boston Scientific Corp. Dr Ingles receives research grant support from Myokardia, Inc. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Publisher Copyright:
© 2021 Heart Rhythm Society
PY - 2021/10
Y1 - 2021/10
N2 - Background: Thorough investigation of sudden cardiac death (SCD) in those aged 1–40 years commonly reveals a heritable cause, yet access to postmortem genetic testing is variable. Objective: The purpose of this study was to explore practices of postmortem genetic testing and attitudes of health care professionals worldwide. Methods: A survey was administered among health care professionals recruited through professional associations, social media, and networks of researchers. Topics included practices around postmortem genetic testing, level of confidence in health care professionals’ ability, and attitudes toward postmortem genetic testing practices. Results: There were 112 respondents, with 93% from North America, Europe, and Australia/New Zealand, and 7% from South America, Asia and Africa. Only 30% reported autopsy as mandatory, and overall practices were largely case by case and not standardized. North American respondents (87%) more often perceived practices as ineffective compared to those from Europe (58%) and Australia/New Zealand (48%; P =.002). Where a heritable cause is suspected, 69% considered postmortem genetic testing and 61% offered genetic counseling to surviving family members. Financial resources varied widely. Half of participants believed practices in their countries perpetuated health inequalities. Conclusion: Postmortem genetic testing is not consistently available in the investigation of young SCD despite being a recommendation in international guidelines. Access to postmortem genetic testing, which is critical in ascertaining a cause of death in many cases, must be guided by well-resourced, multidisciplinary teams.
AB - Background: Thorough investigation of sudden cardiac death (SCD) in those aged 1–40 years commonly reveals a heritable cause, yet access to postmortem genetic testing is variable. Objective: The purpose of this study was to explore practices of postmortem genetic testing and attitudes of health care professionals worldwide. Methods: A survey was administered among health care professionals recruited through professional associations, social media, and networks of researchers. Topics included practices around postmortem genetic testing, level of confidence in health care professionals’ ability, and attitudes toward postmortem genetic testing practices. Results: There were 112 respondents, with 93% from North America, Europe, and Australia/New Zealand, and 7% from South America, Asia and Africa. Only 30% reported autopsy as mandatory, and overall practices were largely case by case and not standardized. North American respondents (87%) more often perceived practices as ineffective compared to those from Europe (58%) and Australia/New Zealand (48%; P =.002). Where a heritable cause is suspected, 69% considered postmortem genetic testing and 61% offered genetic counseling to surviving family members. Financial resources varied widely. Half of participants believed practices in their countries perpetuated health inequalities. Conclusion: Postmortem genetic testing is not consistently available in the investigation of young SCD despite being a recommendation in international guidelines. Access to postmortem genetic testing, which is critical in ascertaining a cause of death in many cases, must be guided by well-resourced, multidisciplinary teams.
KW - Health care professionals
KW - Postmortem genetic testing
KW - Procedures
KW - Sudden cardiac death
KW - Survey
UR - http://www.scopus.com/inward/record.url?scp=85104282642&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85104282642&partnerID=8YFLogxK
U2 - 10.1016/j.hrthm.2021.03.037
DO - 10.1016/j.hrthm.2021.03.037
M3 - Article
C2 - 33781984
AN - SCOPUS:85104282642
SN - 1547-5271
VL - 18
SP - 1637
EP - 1644
JO - Heart Rhythm
JF - Heart Rhythm
IS - 10
ER -